Rainbow Childrens Medicare Q1 FY27 earnings call

Rainbow Children's Medicare Limited reported a strong Q1 FY27, with operating revenue reaching INR 470 crores, marking a 33% year-on-year growth. EBITDA for the quarter stood at INR 134.6 crores, growing 30% year-on-year, resulting in a healthy EBITDA margin of 28.6%. Profit after tax increased by 16% year-on-year to INR 62.5 crores, demonstrating sustained demand and operational efficiency across both mature and newly commissioned hospitals.

The company's total bed capacity grew by 26% to 2,435 beds, with operational bed capacity increasing 22% to 1,862 beds. Rainbow announced a new 100-bed brownfield hospital in Malad, Mumbai, expected to commence operations in Q1 FY28, marking its entry into Western India. Additionally, it acquired a 70-bed hospital in Nellore and leased a 50-bed facility in Guntur, further strengthening its presence in Andhra Pradesh, with these new additions contributing approximately INR 38 crores to revenue this quarter.

Rainbow plans to add 2,500 beds over the next five years, expanding its network capacity to 5,000 beds, with an estimated capex of INR 2,200 crores. The company currently has visibility on 1,200 beds under various stages of development. Management expects to cross INR 2,000 crores in revenue by the end of FY27 and aims to double this revenue over the subsequent four years by sustaining an annual growth rate of around 20%.

Key operating metrics showed healthy growth, with inpatient admissions increasing by 28%, outpatient consultations by 25%, and deliveries by 23%. The average revenue per occupied bed (ARPOB) improved by 6%, driven by expansion into larger markets like Gurugram and Mumbai, and a continued focus on tertiary and quaternary pediatric care, including advanced specialties like liver and kidney transplantation. Occupancy rates improved to over 41%, and ARPOB for mature hospitals (over 5 years old) was approximately INR 70,000, an 18% increase.

The company is strengthening its digital ecosystem by implementing a new CRM platform, lead management system, and increasing investments in digital patient acquisition. It is also redesigning its Hospital Information System (HIS) and building a Business Intelligence platform, with substantial implementation expected within the next 3-4 months. Management emphasized building a strong clinical ecosystem, attracting high-quality medical teams, and engaging with the medical community as critical for success in new markets.

Despite temporary margin pressure from adding nearly 40% bed capacity in the last two years and initial losses from newly commissioned hospitals, management expects EBITDA margins to return to the 24%-25% range (pre-Ind AS basis) by the end of FY27. Rajahmundry hospital is currently at breakeven, and the Electronic City hospital in Bangalore is expected to reach breakeven within the next two to three months, with all new Bengaluru hospitals projected to break even within 18 months.

Rainbow is actively exploring opportunities in high-growth markets in North India (Uttar Pradesh, Bihar, Rajasthan, Haryana), which account for 62% of India's births, and Central India (Indore, Raipur, Bhubaneswar). The strategy involves building a comprehensive presence with a hub-and-spoke model in new geographies, similar to its successful approach in Guwahati, where the business has performed well, and aims to add 70% of planned new capacity in these newer markets.

The company differentiates itself as a tertiary and quaternary pediatric super-specialty hospital that also handles deliveries, offering a complete continuum of care from fertility to advanced pediatric specialties. This integrated model, combined with strong neonatal and pediatric intensive care capabilities, fosters patient stickiness, as families often continue with Rainbow for acute illnesses even if they delivered elsewhere, contributing to a unique competitive advantage.